Success Metrics

Clinical Success Rate
87.0%

Based on 100 completed trials

Completion Rate
87%(100/115)
Active Trials
38(21%)
Results Posted
5%(5 trials)
Terminated
15(8%)

Phase Distribution

Ph phase_1
2
1%
Ph phase_2
7
4%
Ph phase_3
5
3%
Ph not_applicable
31
17%
Ph early_phase_1
1
1%

Phase Distribution

3

Early Stage

7

Mid Stage

5

Late Stage

Phase Distribution46 total trials
Early Phase 1First-in-human
1(2.2%)
Phase 1Safety & dosage
2(4.3%)
Phase 2Efficacy & side effects
7(15.2%)
Phase 3Large-scale testing
5(10.9%)
N/ANon-phased studies
31(67.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.6%

100 of 124 finished

Non-Completion Rate

19.4%

24 ended early

Currently Active

38

trials recruiting

Total Trials

178

all time

Status Distribution
Active(41)
Completed(100)
Terminated(24)
Other(13)

Detailed Status

Completed100
Recruiting29
Terminated15
unknown12
Active, not recruiting9
Withdrawn9

Development Timeline

Analytics

Development Status

Total Trials
178
Active
38
Success Rate
87.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (2.2%)
Phase 12 (4.3%)
Phase 27 (15.2%)
Phase 35 (10.9%)
N/A31 (67.4%)

Trials by Status

active_not_recruiting95%
not_yet_recruiting21%
completed10056%
suspended11%
unknown127%
enrolling_by_invitation11%
recruiting2916%
terminated158%
withdrawn95%

Recent Activity

Clinical Trials (178)

Showing 20 of 178 trialsScroll for more
NCT04778449

Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma

Recruiting
NCT02402244

Project: Every Child for Younger Patients With Cancer

Recruiting
NCT06895681

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

Not Yet Recruiting
NCT04314401

National Cancer Institute "Cancer Moonshot Biobank"

Active Not Recruiting
NCT02970045

Norris ORIEN Total Cancer Care

Recruiting
NCT01627093

Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy

Active Not Recruiting
NCT06042569Phase 2

Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

Recruiting
NCT06492759Phase 2

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

Recruiting
NCT02863107

Young-Onset Colorectal Cancer

Active Not Recruiting
NCT00477100

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

Recruiting
NCT04053517

Financial Distress in Advanced Cancer Patients

Active Not Recruiting
NCT00900471

Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

Recruiting
NCT03737695

Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer

Suspended
NCT04604522

Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome

Recruiting
NCT00830557

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Recruiting
NCT00835133

Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma

Active Not Recruiting
NCT04984551Phase 2

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

Recruiting
NCT04723095

Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

Recruiting
NCT04242095

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Recruiting
NCT01772771

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
178